(Q34393259)

English

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

based on heuristic

inferred from title

medroxyprogesterone acetate

1 reference

based on heuristic

inferred from title

Paolo Vercellini

1

object named as

P Vercellini

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

O De Giorgi

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

S Oldani

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

I Cortesi

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

S Panazza

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

P G Crosignani

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

1 August 1996

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

American Journal of Obstetrics and Gynecology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

175

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

396-401

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Buserelin versus danazol in the treatment of endometriosis-associated infertility

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Very low dose danazol for relief of endometriosis-associated pelvic pain: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Revised American Fertility Society classification of endometriosis: 1985

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Improving the classification of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Drug regulation in the United States and the United Kingdom: the Depo-Provera story.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Resea

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Medical treatment of mild endometriosis in infertile women: analysis of a failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Depression in users of depo-medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Bone density in women receiving depot medroxyprogesterone acetate for contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

DMPA and bone density.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Hormone treatment of endometriosis: the estrogen threshold hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Treatment of endometriosis with estrogen-progestin combination and progestogens alone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9378(96)70152-7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34393259&oldid=1983174492"